Xenetic Biosciences, Inc. (XBIO) Financials
XBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 8.4 million | 968025 |
| Sept. 30, 2025 | 5.1 million | 1.1 million |
| June 30, 2025 | 5.4 million | 903430 |
| March 31, 2025 | 5.8 million | 667927 |
XBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -242682 | 13998 |
| Sept. 30, 2025 | -658250 | 15855 |
| June 30, 2025 | -383830 | 15683 |
| March 31, 2025 | -1.0 million | 19251 |
XBIO Net Income
No data available :(
XBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 7.9 million | - | - |
| Sept. 30, 2025 | 4.1 million | - | - |
| June 30, 2025 | 4.8 million | - | - |
| March 31, 2025 | 5.2 million | - | - |
XBIO Shares Outstanding
XBIO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | 773416 | 615907 | - |
| Sept. 30, 2025 | 3 | 756482 | 815209 | - |
| June 30, 2025 | - | 656557 | 657752 | - |
| March 31, 2025 | 2 | 879029 | 656641 | - |
XBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 766296 | - |
| Sept. 30, 2025 | 1.0 million | - |
| June 30, 2025 | 589897 | - |
| March 31, 2025 | 593261 | - |
XBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
XBIO
Price: $3.25
52 week price:
Earnings Per Share: -1.58 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27600
Ebitda: -8.4 millionMarket Capitalization: 5.3 million